Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOUND AS NMT INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/008512
Kind Code:
A1
Abstract:
The present invention provides a compound having N-myristoyltransferase (NMT) inhibitor activity or a pharmaceutically acceptable salt thereof and a preparation method therefor. The present invention also relates to use of such compound as an N-myristoyltransferase (NMT) inhibitor for preparing a medicament for treating or preventing infectious diseases or hyperproliferative diseases. The infectious diseases include protozoan infections (such as malaria and leishmaniasis) and viral infections (such as human rhinovirus and HIV). The hyperproliferative diseases include lymphoma, leukemia, pancreatic cancer, breast cancer, lung cancer, esophageal cancer, gastric cancer, liver cancer, colorectal cancer, etc.

Inventors:
ZHANG YAN (CN)
WANG ZHENYU (CN)
ZHANG XUEJIAO (CN)
GUO JIANQIAO (CN)
HU JIMING (CN)
HUA XINXING (CN)
CHU WENHAO (CN)
AN HUI (CN)
QIN YANAN (CN)
WU HUIHUI (CN)
MU YONGZHAO (CN)
SHI HUIJING (CN)
GENG JIA (CN)
Application Number:
PCT/CN2020/101813
Publication Date:
January 21, 2021
Filing Date:
July 14, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD (CN)
International Classes:
C07D403/12; A61K31/4155; A61K31/4184; A61K31/423; A61K31/4365; A61K31/4439; A61K31/454; A61K31/4985; A61K31/519; A61K31/5377; A61P31/14; A61P31/18; A61P33/02; A61P33/06; A61P35/00; C07D401/14; C07D405/12; C07D405/14; C07D409/12; C07D409/14; C07D413/12; C07D487/04; C07D495/04
Domestic Patent References:
WO2013083991A12013-06-13
WO2010026365A12010-03-11
Foreign References:
US20180370974A12018-12-27
US20180370974A12018-12-27
CN102209717A2011-10-05
CN107635970A2018-01-26
CN101077866A2007-11-28
Download PDF: